Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?

被引:14
|
作者
Abas, Abdul Hawil [1 ]
Marfuah, Siti [1 ]
Idroes, Rinaldi [2 ]
Kusumawaty, Diah [3 ]
Fatimawali [4 ]
Park, Moon Nyeo [5 ]
Siyadatpanah, Abolghasem [6 ]
Alhumaydhi, Fahad A. [7 ]
Mahmud, Shafi [8 ]
Tallei, Trina Ekawati [1 ]
Bin Emran, Talha [9 ]
Kim, Bonglee [5 ]
机构
[1] Sam Ratulangi Univ, Fac Math & Nat Sci, Dept Biol, Manado 95115, North Sulawesi, Indonesia
[2] Univ Syiah Kuala, Fac Math & Nat Sci, Dept Pharm, Banda Aceh 23111, Aceh, Indonesia
[3] Univ Pendidikan Indonesia, Fac Math & Nat Sci Educ, Dept Biol, Bandung 40154, West Java, Indonesia
[4] Sam Ratulangi Univ, Fac Math & Nat Sci, Pharm Study Program, Manado 95115, North Sulawesi, Indonesia
[5] Kyung Hee Univ, Coll Korean Med, Seoul 05253, South Korea
[6] Birjand Univ Med Sci, Ferdows Sch Paramed & Hlth, Birjand 9717853577, Iran
[7] Qassim Univ, Coll Appl Med Sci, Dept Med Labs, Buraydah 52571, Saudi Arabia
[8] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Canberra, ACT 0200, Australia
[9] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4381, Bangladesh
来源
MOLECULES | 2022年 / 27卷 / 07期
基金
新加坡国家研究基金会;
关键词
COVID-19; SARS-CoV-2; Omicron; natural immunity; hybrid immunity; MAIN PROTEASE; TRANSMISSION; MECHANISMS; INFECTION; VACCINES; FUTURE; ORIGIN;
D O I
10.3390/molecules27072221
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of this pandemic and has claimed over 5 million lives, is still mutating, resulting in numerous variants. One of the newest variants is Omicron, which shows an increase in its transmissibility, but also reportedly reduces hospitalization rates and shows milder symptoms, such as in those who have been vaccinated. As a result, many believe that Omicron provides a natural vaccination, which is the first step toward ending the COVID-19 pandemic. Based on published research and scientific evidence, we review and discuss how the end of this pandemic is predicted to occur as a result of Omicron variants being surpassed in the community. In light of the findings of our research, we believe that it is most likely true that the Omicron variant is a natural way of vaccinating the masses and slowing the spread of this deadly pandemic. While the mutation that causes the Omicron variant is encouraging, subsequent mutations do not guarantee that the disease it causes will be less severe. As the virus continues to evolve, humans must constantly adapt by increasing their immunity through vaccination.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Post COVID-19 condition of the Omicron variant of SARS-CoV-2
    Morioka, S.
    Tsuzuki, S.
    Suzuki, M.
    Terada, M.
    Akashi, M.
    Osanai, Y.
    Kuge, C.
    Sanada, M.
    Tanaka, K.
    Maruki, T.
    Takahashi, K.
    Saito, S.
    Hayakawa, K.
    Teruya, K.
    Hojo, M.
    Ohmagari, N.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (11) : 1546 - 1551
  • [2] Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review
    Du, Yuxuan
    Chen, Long
    Shi, Yuan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [3] mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
    Garcia-Beltran, Wilfredo F.
    St Denis, Kerri J.
    Hoelzemer, Angelique
    Lam, Evan C.
    Nitido, Adam D.
    Sheehan, Maegan L.
    Berrios, Cristhian
    Ofoman, Onosereme
    Chang, Christina C.
    Hauser, Blake M.
    Feldman, Jared
    Roederer, Alex L.
    Gregory, David J.
    Poznansky, Mark C.
    Schmidt, Aaron G.
    Iafrate, A. John
    Naranbhai, Vivek
    Balazs, Alejandro B.
    CELL, 2022, 185 (03) : 457 - +
  • [4] Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
    Karim, Salim S. Abdool
    Karim, Quarraisha Abdool
    LANCET, 2021, 398 (10317): : 2126 - +
  • [5] Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
    Antonio Montes-Gonzalez, Jose
    Arturo Zaragoza-Jimenez, Christian
    Eduardo Antonio-Villa, Neftali
    Fermin-Martinez, Carlos A.
    Ramirez-Garcia, Daniel
    Vargas-Vazquez, Arsenio
    Idania Gutierrez-Vargas, Rosaura
    Garcia-Rodriguez, Gabriel
    Lopez-Gatell, Hugo
    Ivan Valdes-Ferrer, Sergio
    Yaxmehen Bello-Chavolla, Omar
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [6] Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
    Qianqian Cui
    Zhengli Shi
    Duman Yimamaidi
    Ben Hu
    Zhuo Zhang
    Muhammad Saqib
    Ali Zohaib
    Baikadamova Gulnara
    Mukhanbetkaliyev Yersyn
    Zengyun Hu
    Shizhu Li
    Infectious Diseases of Poverty, 12
  • [7] Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
    Zhang, Jianguo
    Chen, Nan
    Zhao, Daguo
    Zhang, Jinhui
    Hu, Zhenkui
    Tao, Zhimin
    FRONTIERS IN MEDICINE, 2022, 9
  • [8] Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
    Cui, Qianqian
    Shi, Zhengli
    Yimamaidi, Duman
    Hu, Ben
    Zhang, Zhuo
    Saqib, Muhammad
    Zohaib, Ali
    Gulnara, Baikadamova
    Yersyn, Mukhanbetkaliyev
    Hu, Zengyun
    Li, Shizhu
    INFECTIOUS DISEASES OF POVERTY, 2023, 12 (01)
  • [9] Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2
    Zhang, Jianguo
    Zhao, Daguo
    Hu, Jianhui
    Huang, Xing
    Gu, Qingqing
    Tao, Zhimin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [10] SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
    Afshar, Zeinab Mohseni
    Pirzaman, Ali Tavakoli
    Karim, Bardia
    Anaraki, Shiva Rahimipour
    Hosseinzadeh, Rezvan
    Pireivatlou, Elaheh Sanjari
    Babazadeh, Arefeh
    Hosseinzadeh, Dariush
    Miri, Seyed Rouhollah
    Sio, Terence T.
    Sullman, Mark J. M.
    Barary, Mohammad
    Ebrahimpour, Soheil
    DIAGNOSTICS, 2023, 13 (03)